S. Zimmerman

发表

Pharmacokinetics and ex vivo susceptibility of cefpodoxime proxetil in patients receiving continuous ambulatory peritoneal dialysis

W. Craig, C. Johnson, A. Ateshkadi, 1993, Antimicrobial Agents and Chemotherapy.

Comparison of Intraperitoneal and Subcutaneous Epoetin Alfa in Peritoneal Dialysis Patients a

M. Kosorok, C. Johnson, S. Zimmerman, 1999, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Carnitine status, plasma lipid profiles, and exercise capacity of dialysis patients: effects of a submaximal exercise program.

F. Nagle, S. Zimmerman, P. Hanson, 1986, Metabolism: clinical and experimental.

Staphylococcus Aureus Peritoneal Catheter-Related Infections: A Cause of Catheter Loss and Peritonitis

S. Zimmerman, Curtis A. Johnson, M. O'Brien, 1988 .

Long-term survivors on peritoneal dialysis.

C. Johnson, S. Zimmerman, M. O'Brien, 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Comparison of Continuous Ambulatory Peritoneal Dialysis and Hemodialysis for Diabetics

S. Zimmerman, G. Mejía, 1985 .

Renal transplantation in patients with systemic lupus erythematosus.

H. Sollinger, S. Zimmerman, F. Belzer, 1983, Archives of internal medicine.

Immunoglobulin A nephropathy.

S. Zimmerman, P. Burkholder, 1975, Archives of internal medicine.

Exercise capacity in hemodialysis, CAPD, and renal transplant patients.

P. Painter, S. Zimmerman, P. Hanson, 1986, Nephron.

Serum Advanced Glycosylation End-Products in Patients on Hemodialysis and CAPD

C. Johnson, A. Ateshkadi, S. Zimmerman, 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Renal disease in the elderly: clinicopathologic analysis of renal disease in 115 elderly patients.

S. Zimmerman, A. Moorthy, 1980, Clinical nephrology.

Immunoglobulin A nephropathy.

S. Zimmerman, P. Burkholder, 1975, Archives of internal medicine.

A multicenter study of noncompliance with continuous ambulatory peritoneal dialysis exchanges in US and Canadian patients.

J. Bargman, B. Delano, S. Zimmerman, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Alternative C3 pathway activiation in pneumococcal glomerulonephritis.

S. Zimmerman, G. Hill, L. Hyman, 1975, The American journal of medicine.

Alternate C3 pathway activation in pneumococcal glomerulonephritis

S. Zimmerman, G. Hill, L. Hyman, 1975 .

Characterization of chronic N,N'-diacetylbenzidine-induced nephropathy.

S. Zimmerman, 1979, The American journal of pathology.

HYDROCARBON EXPOSURE AND CHRONIC GLOMERULONEPHRITIS

S. Zimmerman, G. Beirne, Kenneth Groehler, 1975, The Lancet.

Risk Factors for Peritoneal Dialysis-Related Infections

E. Roecker, S. Zimmerman, M. Wakeen, 1994, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Viscus Perforation in Peritoneal Dialysis Patients: Diagnosis and Outcome

S. Zimmerman, M. Wakeen, Denise Bidwel, 1994, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Progression from minimal or focal to diffuse proliferative lupus nephritis.

S. Zimmerman, J. Bloodworth, P. Burkholder, 1975, Laboratory investigation; a journal of technical methods and pathology.

Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections.

W. Craig, E. Roecker, C. Johnson, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A dialysis modality decision guide based on the experience of six dialysis centers

M. Schreiber, R. Hamburger, S. Zimmerman, 1990 .

INHIBITION OF LYMPHOCYTE BLASTOGENESIS BY PLASMA OF PATIENTS WITH MINIMAL-CHANGE NEPHROTIC SYNDROME

S. Zimmerman, P. Burkholder, A. Moorthy, 1976, The Lancet.

Characteristics of Long Term Peritoneal Dialysis Survivors: 18 Years Experience in One Center

E. Abdel-Rahman, S. Zimmerman, M. Wakeen, 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Clinical Pharmacokinetics During Continuous Ambulatory

E. Abdel-Rahman, S. Zimmerman, Curtis A. Johnson, 1996, Clinical pharmacokinetics.

Computerized Tomographic Assessment of Retroperitoneal Hemorrhage After Percutaneous Renal Biopsy

S. Zimmerman, A. Alter, C. Kirachaiwanich, 1980 .

Human leukocyte response to an endurance race

S. Zimmerman, A. Moorthy, 1978, European Journal of Applied Physiology and Occupational Physiology.

Erythropoietin use in peritoneal dialysis patients.

C. Johnson, S. Zimmerman, 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The Pharmacokinetics of Antibiotics Used to Treat Peritoneal Dialysis-Associated Peritonitis

M. Rogge, S. Zimmerman, Curtis A. Johnson, 1984 .

The role of exercise in the long term rehabilitation of patients with end stage renal disease.

P. Painter, S. Zimmerman, 1983, AANNT journal.

Renal replacement therapy in diabetic nephropathy.

D. Cole, H. Sollinger, S. Zimmerman, 1994, Advances in renal replacement therapy.

A Randomized Multicenter Clinical Trial to Evaluate the Effects of An Ultraviolet Germicidal System on Peritonitis Rate in Continuous Ambulatory Peritoneal Dialysis

R. Hamburger, S. Zimmerman, K. Nolph, 1985 .

IDIOPATHIC CRESCENTIC GLOMERULONEPHRITIS

S. Zimmerman, J. P. Wagnild, P. Burkholder, 1977, Medicine.

Ampicillin and Sulbactam Pharmacokinetics and Pharmacodynamics in Continuous Ambulatory Peritoneal Dialysis (CAPD)

W. Craig, S. Zimmerman, J. Leggett, 1990, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Pharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysis

W. Craig, C. Johnson, S. Zimmerman, 1988, Antimicrobial Agents and Chemotherapy.

Rifampin Use in Peritoneal Dialysis

C. Johnson, S. Zimmerman, Curtis A. Johnson, 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Multiple Dose IP Vancomycin Kinetics during CAPD

P. Welling, M. Rogge, S. Zimmerman, 1986 .

Plasmapheresis and dipyridamole for recurrent focal glomerular sclerosis.

S. Zimmerman, 1985, Nephron.

Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation.

S. Zimmerman, 1984, Clinical nephrology.

Nephropathy and mixed cryoglobulinemia: evidence for an immune complex pathogenesis.

S. Goldfarb, S. Zimmerman, P. Burkholder, 1976, Nephron.

Association of crescentic glomerulonephritis with membranous glomerulonephropathy: a report of three cases.

S. Zimmerman, P. Burkholder, A. Moorthy, 1976, Clinical nephrology.

Pharmacokinetics of intraperitoneal epoetin alfa in patients on peritoneal dialysis using an 8-hour "dry dwell" dosing technique.

M. Kosorok, C. Johnson, S. Zimmerman, 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Pharmacokinetics of intraperitoneal, intravenous, and subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.

C. Johnson, A. Ateshkadi, S. Zimmerman, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Pharmacokinetics of Quinupristin-Dalfopristin in Continuous Ambulatory Peritoneal Dialysis Patients

S. Zimmerman, W. Bridson, P. Chevalier, 1999, Antimicrobial Agents and Chemotherapy.

Computerized tomographic assessment of retroperitoneal hemorrhage after percutaneous renal biopsy.

S. Zimmerman, A. Alter, C. Kirachaiwanich, 1981, Archives of Internal Medicine.

Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study.

B. Piraino, R. Swartz, E. Vonesh, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Single‐dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease

J. Haynes, S. Zimmerman, C. Halstenson, 1992, Clinical pharmacology and therapeutics.

Nephrotic syndrome in Hodgkin's disease. Evidence for pathogenesis alternative to immune complex deposition.

S. Zimmerman, P. Burkholder, A. Moorthy, 1976, The American journal of medicine.

Pharmacokinetics of oral cephradine in continuous ambulatory peritoneal dialysis patients.

P. Welling, C. Johnson, S. Zimmerman, 1984, Nephron.

Vesicoureteral reflux nephropathy. Evidence for immunologically mediated glomerular injury.

S. Zimmerman, D. Uehling, P. Burkholder, 1973, Urology.

THE EFFECTS OF EXERCISE TRAINING ON CARNITINE STATUS AND PHYSICAL WORK CAPACITY IN DIALYSIS PATIENTS

F. Nagle, S. Zimmerman, P. Hanson, 1982 .

Heparin therapy for the renal disease of malignant hypertension.

S. Zimmerman, J. Bergin, 1974, Nephron.

Recurrent membranoproliferative glomerulonephritis with glomerular properdin deposition in allografts.

S. Zimmerman, D. Uehling, L. Hyman, 1974, Annals of internal medicine.

Pharmacokinetics of Tazobactam M1 Metabolite After Administration of Piperacillin/Tazobactam in Subjects with Renal Impairment

W. Keane, C. Lathia, K. Tantillo, 1994, Journal of clinical pharmacology.

Prospective trial of warfarin and dipyridamole in patients with membranoproliferative glomerulonephritis.

S. Zimmerman, A. Friedman, W. Dreher, 1983, The American journal of medicine.

Intraperitoneal V Ancoled Does Not Cause Chemical Peritonitis

C. Johnson, S. Zimmerman, 1989, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

Intraperitoneal Vancoled does not cause chemical peritonitis.

C. Johnson, S. Zimmerman, 1989, Peritoneal Dialysis International.

Pneumoperitoneum in Peritoneal Dialysis Patients: Significance of Diagnosis by CT

T. Hammond, S. Zimmerman, F. Lee, 1994, Journal of computer assisted tomography.

Immunohistologic features of minimal-change nephrotic syndrome.

S. Zimmerman, P. Burkholder, D. R. Prasad, 1977, Archives of Pathology & Laboratory Medicine.

Dermatitis herpetiformis and celiac disease: association with glomerulonephritis, hypocomplementia, and circulating immune complexes.

S. Zimmerman, A. Moorthy, P. Maxim, 1978, JAMA.

Goodpasture's syndrome with normal renal function.

S. Zimmerman, B. Hoff, U. Varanasi, 1979, The American journal of medicine.

Goodpasture syndrome. Dissociation from antibodies to glomerular basement membrane.

S. Zimmerman, G. Beirne, W. L. Kopp, 1973, Archives of internal medicine.

Vancomycin disposition during continuous ambulatory peritoneal dialysis: a pharmacokinetic analysis of peritoneal drug transport

P. Welling, M. Rogge, C. Johnson, 1985, Antimicrobial Agents and Chemotherapy.

Continuous Ambulatory Peritoneal Dialysis in Diabetes mellitus

S. Zimmerman, D. Simpson, M. Madden, 1982 .

Continuous ambulatory peritoneal dialysis in diabetes mellitus. The risks and benefits of intraperitoneal insulin.

S. Zimmerman, D. Simpson, M. Madden, 1982, American journal of nephrology.

Long-term outcome of diabetic patients receiving peritoneal dialysis.

S. Zimmerman, M. Wakeen, L. Oxton, 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Treatment of End‐Stage Diabetic Nephropathy: Over a Decade of Experience at One Institution

H. Sollinger, S. Zimmerman, F. Belzer, 1984, Medicine.

Exertional heatstroke in novice runners.

S. Zimmerman, P. Hanson, 1979, JAMA.

Acute bowel obstruction: an unusual complication of chronic peritoneal dialysis.

H. Sollinger, S. Zimmerman, G. Beirne, 1982, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association between human recombinant EPO and peripheral vascular disease in diabetic patients receiving peritoneal dialysis.

S. Zimmerman, M. Wakeen, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

CHAPTER 59 – Treatment of Anemia in Peritoneal Dialysis Patients

S. Zimmerman, M. Wakeen, Curtis A. Johnson, 2008 .

Exercise tolerance changes following renal transplantation.

P. Painter, S. Zimmerman, P. Hanson, 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Renal Transplantation in Patients on Peritoneal Dialysis

H. Sollinger, S. Zimmerman, F. Belzer, 1985 .

Chronic Peritoneal Dialysis is Associated with Progressive Thrombocytosis

S. Zimmerman, 1986 .

Hepatic and mesenteric artery resistances after sinoaortic denervation and hemorrhage.

S. Zimmerman, G. Mundschau, Q. Murphy, 1966, American Journal of Physiology.

Skin lesions treated with azathioprine and prednisone. Comparison of nontransplant patients and renal transplant recipients.

S. Zimmerman, J. Esch, 1978, Archives of Internal Medicine.

The Diabetic Esrd Patient: Specific Needs

S. Zimmerman, S. Zimmerman, 1997, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

Management of Fulminating Thrombotic Thrombocytopenic Purpura

C. Johnson, S. Zimmerman, S. Updike, 1981, Seminars in thrombosis and hemostasis.

Rofecoxib-induced acute interstitial nephritis.

S. Zimmerman, S. Updike, N. Alim, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.